CalcMyPeptide
Cosmetic PeptideAlso known as: Palmitoyl pentapeptide-4, Pal-KTTKS, Matrixyl 3000

Matrixyl

Lipopeptide signaling fragment of collagen — stimulates fibroblasts to synthesize collagen I, III, IV, glycosaminoglycans, and fibronectin. Widely used in anti-aging skincare.

Half-Life
~6 hours (topical)
Dose Range
2-8% topical solution
Frequency
1-2× daily (topical)
Vial Sizes
N/A (oral)

🔬 Mechanism of Action

Matrixyl (palmitoyl pentapeptide-4, Pal-KTTKS) consists of the pentapeptide sequence Lys-Thr-Thr-Lys-Ser conjugated to a palmitic acid chain for enhanced skin penetration. The KTTKS sequence is a fragment of the C-terminal propeptide of type I procollagen — when collagen is broken down, this fragment acts as a matrikine (ECM-derived signaling molecule) that triggers the wound-repair cascade. It signals dermal fibroblasts via integrin receptors (particularly αvβ5) to upregulate synthesis of collagen types I, III, and IV, fibronectin, elastin, and glycosaminoglycans. Clinical trials demonstrate significant improvement in wrinkle depth and skin roughness after 4-12 weeks of twice-daily application.

Source: PMID: 15698725

📜Background & History

Matrixyl (palmitoyl pentapeptide-4) was developed by Sederma (France) and became one of the most extensively studied cosmetic peptides. The KTTKS sequence was identified from type I procollagen propeptide fragments, and its palmitoylation was a key innovation enabling skin penetration. Clinical trials published in the International Journal of Cosmetic Science demonstrated statistically significant wrinkle depth reduction. "Matrixyl 3000" is a later formulation combining palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7.

🎯 Research Use Cases

  • Collagen stimulation
  • Wrinkle depth reduction
  • Skin firmness improvement
  • ECM replenishment
  • Photo-aging recovery

💉 Dosing Protocol

Typical Dose2-8% topical solution
Frequency1-2× daily (topical)
Half-Life~6 hours (topical)

⚠️Safety & Considerations

Excellent topical safety profile. No sensitization in clinical testing. Often combined with Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) for synergistic effects on collagen synthesis and inflammation.

Interactions & Contraindications

Topical only. Stable in most cosmetic formulations. Compatible with retinoids, antioxidants, and other peptides. The palmitoyl chain may influence absorption from different vehicle types.

🔗Synergies & Common Stacks

Matrixyl (rebuilds) + Argireline (relaxes) = comprehensive approach to both structural aging and dynamic wrinkles.

Matrixyl and GHK-Cu both stimulate collagen synthesis but through different mechanisms: Matrixyl via matrikine signaling, GHK-Cu via gene expression modulation.

📊 Dosing Quick Reference

Matrixyl— Dosing Guide
Dose Range
2-8% topical solution
Half-Life
~6 hours (topical)
Frequency
1-2× daily (topical)
Route
Oral
Cosmetic Peptidecalcmypeptide.com

Frequently Asked Questions

What is the difference between Matrixyl and Matrixyl 3000?
Original Matrixyl (Pal-KTTKS) stimulates collagen synthesis. Matrixyl 3000 is a newer blend of palmitoyl tripeptide-1 (collagen stimulation) + palmitoyl tetrapeptide-7 (anti-inflammatory). They work synergistically and are often combined in premium formulations.